My watch list
my.bionity.com  
Login  
NEWS
Current news

Chewing gum rapid test for inflammation

Chewing gum to screen for oral inflammation

Dental implants occasionally entail complications: Six to fifteen percent of patients develop an inflammatory response in the years after receiving a dental implant. This is caused by bacteria destroying the soft tissue and the bone around the implant in the worst case. In future, patients ... more

How protein islands form

Researchers identify protein that inhibits the development of autoimmune diseases

The immune system protects humans from threats such as, for example, disease-causing bacteria, and cancer as well. Yet if the system malfunctions, it can attack the body it is supposed to defend and cause autoimmune diseases such as type one diabetes mellitus or multiple sclerosis. The work ... more

Gold shines through properties of nano biosensors

Fluorescence in ligand-protected gold nanoclusters is an intrinsic property of the gold particles themselves

With their remarkable electrical and optical properties, along with biocompatibility, photostability and chemical stability, gold nanoclusters are gaining a foothold in a number of research areas, particularly in biosensing and biolabeling. These gold nanoclusters are chemically protected b ... more

Circular RNA linked to brain function

For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders. While hu ... more

RNA: a vicious pathway to cancer?

According to the current doctrine, cancer cells develop due to mutations in genomic DNA. But could it be also caused also by faulty RNA molecules? A number of clues are pointing to this surprising hypothesis. Rolf Marschalek from the Institute of Pharmaceutical Biology at Goethe University ... more

Cancer detection with sugar molecules

Scientists from the University of Würzburg have synthesized a complex sugar molecule which specifically binds to the tumor protein Galectin-1. This could help to recognize tumors at an early stage and to combat them in a targeted manner. Galectins are a family of proteins that have become ... more

Many proteins must set to work so as to activate fat

New insights into the fuctions of fat metabolism

What happens and where, when the body’s fat stores are activated? With the support of the Austrian Science Fund FWF, the biochemist Ruth Birner-Grünberger investigates the complex interaction of activation and regulation in fat breakdown, thus providing a basis for new therapeutic approache ... more

Drug Approval: New Country Comparison Shows Great Savings Potential

The regulatory requirements for the approval of new drugs vary greatly internationally in regards to the resources allocated to the authorities, the evaluation periods for approval and the fees for the pharmaceutical companies. This reports a study of the European Center of Pharmaceutical M ... more

Eppendorf grows faster than the market

During the first half of 2017, the Eppendorf Group achieved group sales of €327.9 million (prior-year period: €305.5 million). At 7.3% (6.6% when adjusted for currency effects), growth in sales lay above average market growth in the life science industry. Income from operations (EBIT) climb ... more

analytica China 2018: Bigger and new layout

Asia’s leading trade show for analysis, lab technology and biotechnology, analytica China, will open again at Hall E1 to E4, Shanghai New International Expo Center from October 31 to November 2, 2018. The exhibition is a spin-off of analytica in Germany—the leading international fair for la ... more

All news

analytica China 2018: Bigger and new layout

Asia’s leading trade show for analysis, lab technology and biotechnology, analytica China, will open again at Hall E1 to E4, Shanghai New International Expo Center from October 31 to November 2, 2018. The exhibition is a spin-off of analytica in Germany—the leading international fair for la ... more

High resolution without particle accelerator

Physicists are first to achieve optical coherence tomography with XUV radiation at laboratory scale

A visit to the optometrist often involves optical coherence tomography. This imaging process uses infrared radiation to penetrate the layers of the retina and examine it more closely in three dimensions, without having to touch the eye at all. This allows eye specialists to diagnose disease ... more

New, more sensitive sensor for evaluating drug safety

A new technique for evaluating drug safety can detect stress on cells at earlier stages than conventional methods, which mostly rely on detecting cell death. The new method uses a fluorescent sensor that is turned on in a cell when misfolded proteins begin to aggregate -- an early sign of c ... more

Multiple roles of glucose metabolism in platelet activation and survival identified

Platelets, the cells in blood that enable clotting, are highly reliant on their ability to metabolize glucose, according to a new study by researchers at the University of Iowa. The findings may have implications for understanding the increased risk of thrombosis--blood clots inside blood v ... more

Unknown virus in ‘throwaway’ DNA discovered

A chance discovery has opened up a new method of finding unknown viruses

In research scientists from Oxford University’s Department of Zoology have revealed that Next-Generation Sequencing and its associated online DNA databases could be used in the field of viral discovery. They have developed algorithms that detect DNA from viruses that happen to be in the blo ... more

Lifelike 3-D cinematic imaging promises numerous medical uses

Newly developed "cinematic rendering" technology can produce photorealistic 3D images from traditional CT and MRI data, with potential applications in medical education, communication with patients and physicians, and early disease detection. Recently introduced and not currently approved f ... more

Cell senescence is regulated by innate DNA sensing

Cells in the body or in cultures eventually stop replicating. This phenomenon is called "senescence" and is triggered by shortening of telomeres, oxidative stress or genetic damage to the cells, either acute or simply due to the cell growing "old". Understanding the causes and impact of sen ... more

Cheap and simple detection of neurotoxic chemicals

There is a limited amount of data on the global health impacts of pesticides, but many injuries and deaths worldwide can be attributed to their misuse. Pesticide contamination of food and water sources is a very serious problem, particularly in third world countries. The detection of these ... more

Computer models provide new understanding of sickle cell disease

Computer models developed by Brown University mathematicians show new details of what happens inside a red blood cell affected by sickle cell disease. The researchers said they hope their models will help in assessing drug strategies to combat the genetic blood disorder, which affects milli ... more

How bacteria maintain and recover their shape

Bacteria come in all shapes and sizes -- some are straight as a rod, others twist like a corkscrew. Shape plays an important role in how bacteria infiltrate and attack cells in the body. The helical shape of Helicobacter pylori, a species of bacteria which can cause ulcers, may help it pene ... more

All news on bioanalytics

analytica China 2018: Bigger and new layout

Asia’s leading trade show for analysis, lab technology and biotechnology, analytica China, will open again at Hall E1 to E4, Shanghai New International Expo Center from October 31 to November 2, 2018. The exhibition is a spin-off of analytica in Germany—the leading international fair for la ... more

Multi-nutrient rice against malnutrition

First multi-nutrient rice

ETH researchers have developed a new rice variety that not only has increased levels of the micronutrients iron and zinc in the grains, but also produces beta-carotene as a precursor of vitamin A. This could help to reduce micronutrient malnutrition, or «hidden hunger», which is widespread ... more

Medigene announces formation of new Scientific Advisory Board

Medigene AG announced the appointment of eight leading experts to its new immuno-oncology-focused Scientific Advisory Board (SAB). The SAB will consult the company with regard to strategic options and future perspectives within its research and development activities. The SAB will thereby f ... more

"Origami organs" can potentially regenerate tissues

Bioactive tissue paper made from organs is pliable enough to fold into origami structures

Northwestern Medicine scientists and engineers have invented a range of bioactive "tissue papers" made of materials derived from organs that are thin and flexible enough to even fold into an origami bird. The new biomaterials can potentially be used to support natural hormone production in ... more

Microbot origami can capture, transport single cells

Researchers at North Carolina State University and Duke University have developed a way to assemble and pre-program tiny structures made from microscopic cubes - "microbot origami" - to change their shape when actuated by a magnetic field and then, using the magnetic energy from their envir ... more

Multiple roles of glucose metabolism in platelet activation and survival identified

Platelets, the cells in blood that enable clotting, are highly reliant on their ability to metabolize glucose, according to a new study by researchers at the University of Iowa. The findings may have implications for understanding the increased risk of thrombosis--blood clots inside blood v ... more

Immune cells may be key to better allergy, infection therapies

By learning how a recently discovered immune cell works in the body, researchers hope to one day harness the cells to better treat allergies and infections, according to new Cornell University research. Type 1 regulatory (Tr1) cells are a type of regulatory immune cell that help suppress im ... more

Unknown virus in ‘throwaway’ DNA discovered

A chance discovery has opened up a new method of finding unknown viruses

In research scientists from Oxford University’s Department of Zoology have revealed that Next-Generation Sequencing and its associated online DNA databases could be used in the field of viral discovery. They have developed algorithms that detect DNA from viruses that happen to be in the blo ... more

Lonza Acquires Micro-Macinazione

Swiss company expert in the field of microniziation

Lonza has acquired Micro-Macinazione, providing micronization of active ingredients for the pharmaceutical and fine chemical industries. Micro-Macinazione, which had sales of ~ CHF 20 million in 2016, has 120 employees and is based in Monteggio, Switzerland. Micro-Macinazione was purchased ... more

EPA to Grant Merck’s Patent Application for CRISPR Technology

Related patent application recently awarded in Australia

Merck announced the European Patent Office (EPO) has issued a “Notice of Intention to Grant” for Merck’s patent application covering the company’s CRISPR technology used in a genomic integration method for eukaryotic cells. The patent will provide Merck’s CRISPR genomic integration technolo ... more

All news on biotechnology

Chewing gum rapid test for inflammation

Chewing gum to screen for oral inflammation

Dental implants occasionally entail complications: Six to fifteen percent of patients develop an inflammatory response in the years after receiving a dental implant. This is caused by bacteria destroying the soft tissue and the bone around the implant in the worst case. In future, patients ... more

Cancer detection with sugar molecules

Scientists from the University of Würzburg have synthesized a complex sugar molecule which specifically binds to the tumor protein Galectin-1. This could help to recognize tumors at an early stage and to combat them in a targeted manner. Galectins are a family of proteins that have become ... more

analytica China 2018: Bigger and new layout

Asia’s leading trade show for analysis, lab technology and biotechnology, analytica China, will open again at Hall E1 to E4, Shanghai New International Expo Center from October 31 to November 2, 2018. The exhibition is a spin-off of analytica in Germany—the leading international fair for la ... more

New biomarker found for group of rare metabolic diseases

A newly discovered biomarker associated with a rare metabolic disorder may facilitate better diagnosis and identification of new drugs for clinical trials for the disease, according to researchers in the Perelman School of Medicine at the University of Pennsylvania. Development of treatment ... more

New, more sensitive sensor for evaluating drug safety

A new technique for evaluating drug safety can detect stress on cells at earlier stages than conventional methods, which mostly rely on detecting cell death. The new method uses a fluorescent sensor that is turned on in a cell when misfolded proteins begin to aggregate -- an early sign of c ... more

Imaging tracer allows early assessment of abdominal aortic aneurysm risk

Yale University researchers have developed a way in which medical imaging could potentially be used to assess a patient's rupture risk for abdominal aortic aneurysm. Delaying surgical treatment can be life-threatening, and this new type of imaging could allow physicians to diagnose disease ... more

Lifelike 3-D cinematic imaging promises numerous medical uses

Newly developed "cinematic rendering" technology can produce photorealistic 3D images from traditional CT and MRI data, with potential applications in medical education, communication with patients and physicians, and early disease detection. Recently introduced and not currently approved f ... more

Beware doping athletes! This sensor may be your downfall

Scientists searching for traces of drugs, bomb-making components and other chemicals often shine light on the materials they're analyzing. This approach is known as spectroscopy, and it involves studying how light interacts with trace amounts of matter. One of the more effective types of sp ... more

Cheap and simple detection of neurotoxic chemicals

There is a limited amount of data on the global health impacts of pesticides, but many injuries and deaths worldwide can be attributed to their misuse. Pesticide contamination of food and water sources is a very serious problem, particularly in third world countries. The detection of these ... more

Computer models provide new understanding of sickle cell disease

Computer models developed by Brown University mathematicians show new details of what happens inside a red blood cell affected by sickle cell disease. The researchers said they hope their models will help in assessing drug strategies to combat the genetic blood disorder, which affects milli ... more

All news on diagnostics

Eppendorf grows faster than the market

During the first half of 2017, the Eppendorf Group achieved group sales of €327.9 million (prior-year period: €305.5 million). At 7.3% (6.6% when adjusted for currency effects), growth in sales lay above average market growth in the life science industry. Income from operations (EBIT) climb ... more

analytica China 2018: Bigger and new layout

Asia’s leading trade show for analysis, lab technology and biotechnology, analytica China, will open again at Hall E1 to E4, Shanghai New International Expo Center from October 31 to November 2, 2018. The exhibition is a spin-off of analytica in Germany—the leading international fair for la ... more

Building bridges within the cell - using light

Each cell in the body is made up of a number of tiny sealed membranous subunits called organelles, and they send things like lipids back and forth to allow the cell to function. A process called membrane tethering is responsible for bridging the gap between organelles at a specialized subce ... more

Nitric oxide-releasing nanoparticles reveals viable skin infection treatment

George Washington University (GW) researchers have found that topically applied nitric oxide-releasing nanoparticles (NO-np) are a viable treatment for deep fungal infections of the skin caused by dermatophytes, for which the current standard of care is treatment with systemic antifungals. ... more

New tool to distinguish between viral, bacterial infections

Antibiotics are lifesaving drugs, but overuse is leading to one of the world's most pressing health threats: antibiotic resistance. Researchers at the University of Rochester Medical Center are developing a tool to help physicians prescribe antibiotics to patients who really need them, and ... more

New 3-D imaging reveals how human cell nucleus organizes DNA and chromatin of its genome

Sixty-four years ago, James Watson and Francis Crick described the now-iconic double helix structure of DNA. A team of researchers at the University of California San Diego School of Medicine and the Salk Institute for Biological Studies describe development and application of new electron ... more

ZEISS Opts for Continuity: CEO Kaschke confirmed until 2020

Executive Board Members Monz and Metz will also continue

The Supervisory Board of Carl Zeiss AG has decided to continue the appointment of Dr. Michael Kaschke as President & CEO until 30 June 2020. Kaschke joined the ZEISS Group 25 years ago and has served on the Executive Board since 2000. He has been President & CEO of Carl Zeiss AG since 2011. ... more

Agilent Technologies acquires raman spectroscopy innovator

Agilent Technologies Inc. announced it has acquired Oxfordshire, U.K.-based Cobalt Light Systems, a provider of highly differentiated Raman spectroscopic instruments for the pharmaceutical industry, applied markets and public safety. Cobalt’s innovative suite of benchtop and handheld/porta ... more

Start-ups profit from being in close contact with the venture capital scene

Eight science teams give presentations at 3rd Munich Life Science Pitch Day at IZB

High-Tech Gründerfonds, Bayer Pharma AG, Merck KGaA and the Innovation and Startup Center for Biotechnology (IZB) hosted the 3rd Munich Life Science Pitch Day at the IZB. Eight start-up teams had the opportunity to present their pioneering projects in front of 15 renowned venture capital an ... more

Greener molecular intermediates may aid drug design

Scientists at Rice University have simplified their approach to synthesize a highly versatile family of precursors en route to biologically active compounds. Their method should make drug design and development cheaper and more environmentally friendly. Synthetic chemist László Kürti and po ... more

All news on lab technology

Drug Approval: New Country Comparison Shows Great Savings Potential

The regulatory requirements for the approval of new drugs vary greatly internationally in regards to the resources allocated to the authorities, the evaluation periods for approval and the fees for the pharmaceutical companies. This reports a study of the European Center of Pharmaceutical M ... more

New therapy to combat skin cancer

Neu-Ulm-based medical device producer and High-Tech Gründerfonds found spin-off Zimmer BioTech

In the field of dermatology, Zimmer MedizinSysteme GmbH, a company based in Neu-Ulm (southern Germany), has long been the global market leader for cryotherapy products. In founding the spin-off Zimmer BioTech, the company is now taking another step forward and utilising its wealth of experi ... more

Merck and Baylor College of Medicine Advance Vaccine Development and Manufacturing for Neglected Diseases

Merck announced that it has formed a strategic alliance with Baylor College of Medicine (Texas, U.S.) and its vaccine product development partnership (PDP), Texas Children’s Hospital Center for Vaccine Development (Texas Children’s CVD), to advance vaccine research and development for negle ... more

Medigene announces formation of new Scientific Advisory Board

Medigene AG announced the appointment of eight leading experts to its new immuno-oncology-focused Scientific Advisory Board (SAB). The SAB will consult the company with regard to strategic options and future perspectives within its research and development activities. The SAB will thereby f ... more

Common, edible mushroom has potential to kill one type of leukemia cell

An edible, shaggy-looking mushroom contains a protein that is a potent killer of a certain leukemia cell, a group of University of Florida researchers has found. The Coprinus comatus mushroom, commonly known as the lawyer’s wig or shaggy mane, killed human T-cell leukemia cells during labor ... more

Drug short-circuits cancer signaling

Researchers at Sanford Burnham Prebys Medical Discovery Institute (SBP) have published a study shedding new light on how K-80003 (TX803), an anti-cancer agent discovered at the Institute, prevents activation of the PI3K pathway, resulting in inhibition of cancer cell growth. Because the PI3 ... more

Immune cells may be key to better allergy, infection therapies

By learning how a recently discovered immune cell works in the body, researchers hope to one day harness the cells to better treat allergies and infections, according to new Cornell University research. Type 1 regulatory (Tr1) cells are a type of regulatory immune cell that help suppress im ... more

EPA to Grant Merck’s Patent Application for CRISPR Technology

Related patent application recently awarded in Australia

Merck announced the European Patent Office (EPO) has issued a “Notice of Intention to Grant” for Merck’s patent application covering the company’s CRISPR technology used in a genomic integration method for eukaryotic cells. The patent will provide Merck’s CRISPR genomic integration technolo ... more

Executive Board Changes at Merck

The Personnel Committee of E. Merck KG has decided on changes in the responsibilities of the Executive Board of Merck KGaA, Darmstadt, effective September 1, 2017. Walter Galinat (61) will hand over responsibility for the Performance Materials business of Merck to his Executive Board collea ... more

Merck Sets Course for Future Growth

Life Science and Healthcare drive organic growth

Merck reported an increase in sales in the second quarter of 2017 along with a decline in EBITDA pre exceptionals compared with the year-earlier period. Merck confirmed its earnings guidance following the first six months of 2017. “We have set the course for future growth. By focusing on in ... more

All news on pharma

How protein islands form

Researchers identify protein that inhibits the development of autoimmune diseases

The immune system protects humans from threats such as, for example, disease-causing bacteria, and cancer as well. Yet if the system malfunctions, it can attack the body it is supposed to defend and cause autoimmune diseases such as type one diabetes mellitus or multiple sclerosis. The work ... more

Circular RNA linked to brain function

For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders. While hu ... more

RNA: a vicious pathway to cancer?

According to the current doctrine, cancer cells develop due to mutations in genomic DNA. But could it be also caused also by faulty RNA molecules? A number of clues are pointing to this surprising hypothesis. Rolf Marschalek from the Institute of Pharmaceutical Biology at Goethe University ... more

Cancer detection with sugar molecules

Scientists from the University of Würzburg have synthesized a complex sugar molecule which specifically binds to the tumor protein Galectin-1. This could help to recognize tumors at an early stage and to combat them in a targeted manner. Galectins are a family of proteins that have become ... more

Researchers discover new genetic mutation that causes male infertility

Researchers at Ben-Gurion University of the Negev and Soroka University Medical Center in Beer-Sheva, Israel have discovered a new genetic mutation that prevents sperm production. Five percent of men suffer from infertility and approximately one percent suffer from azoospermia, which is a c ... more

How food preservatives may disrupt human hormones and promote obesity

Innovative stem-cell testing system demonstrates potential for evaluating health effects of chemicals used in everyday life

Can chemicals that are added to breakfast cereals and other everyday products make you obese? Growing evidence from animal experiments suggests the answer may be "yes." But confirming these findings in humans has faced formidable obstacles - until now. A new study published in Nature Commun ... more

Spider peptides battle superbugs and cancer

As antibiotic resistance rises and fears over superbugs grow, scientists are looking for new treatment options. One area of focus is antimicrobial peptides (AMPs), which could someday be an alternative to currently prescribed antibiotics, many of which are becoming increasingly useless agai ... more

Medication for the unborn baby

New 3D model of the human placental barrier

An Empa team has succeeded in developing a new three-dimensional cell model of the human placental barrier. The "model organ" can quickly and reliably deliver new information on the intake of substances, such as nano-particles, by the placental barrier and on any possible toxic effects for ... more

New anti-malarial lead compound successfully tested

Researchers in a team headed by Professor Thomas Kurz at the Institute of Pharmaceutical and Medicinal Chemistry of Heinrich Heine University Düsseldorf (HHU) have successfully tested an optimised lead compound in animal experiments that acts against plasmodia, i.e. malaria parasites. Lead ... more

Common, edible mushroom has potential to kill one type of leukemia cell

An edible, shaggy-looking mushroom contains a protein that is a potent killer of a certain leukemia cell, a group of University of Florida researchers has found. The Coprinus comatus mushroom, commonly known as the lawyer’s wig or shaggy mane, killed human T-cell leukemia cells during labor ... more

All news on healthcare
News by department
  • Products

    Drug Approval: New Country Comparison Shows Great Savings Potential

    The regulatory requirements for the approval of new drugs vary greatly internationally in regards to the resources allocated to the authorities, the evaluation periods for approval and the fees for the pharmaceutical companies. This reports a study of the European Center of Pharmaceutical M ... more

    EMA’s CHMP Issues Positive Opinion for Avelumab for the Treatment of Metastatic Merkel Cell Carcinoma

    Decision by the EC is expected in the third quarter of 2017

    Merck and Pfizer Inc. announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended the approval of avelumab (BAVENCIO®) as a monotherapy for the treatment of adult patients with metastatic Merkel cell carcinoma (mMCC), a rar ... more

    Sartorius and Science magazine to award prize for regenerative medicine and cell therapy

    Sartorius together with the Science magazine will award a Sartorius & Science Prize for Regenerative Medicine & Cell Therapy. This prestigious annual award is geared towards exceptional scientists who focus on achieving advancements in basic or translational research in these areas. All sci ... more

  • Business

    analytica China 2018: Bigger and new layout

    Asia’s leading trade show for analysis, lab technology and biotechnology, analytica China, will open again at Hall E1 to E4, Shanghai New International Expo Center from October 31 to November 2, 2018. The exhibition is a spin-off of analytica in Germany—the leading international fair for la ... more

    New therapy to combat skin cancer

    Neu-Ulm-based medical device producer and High-Tech Gründerfonds found spin-off Zimmer BioTech

    In the field of dermatology, Zimmer MedizinSysteme GmbH, a company based in Neu-Ulm (southern Germany), has long been the global market leader for cryotherapy products. In founding the spin-off Zimmer BioTech, the company is now taking another step forward and utilising its wealth of experi ... more

    Medigene announces formation of new Scientific Advisory Board

    Medigene AG announced the appointment of eight leading experts to its new immuno-oncology-focused Scientific Advisory Board (SAB). The SAB will consult the company with regard to strategic options and future perspectives within its research and development activities. The SAB will thereby f ... more

  • Price Development

    Drug costs vary by more than 600% in study of 10 high-income countries

    In a study of 10 high-income countries with universal health care, costs for prescription drugs in 6 of the largest categories of primary care medicines varied by more than 600%. All countries except Canada offered universal coverage of outpatient prescription drugs. The study looked at dat ... more

    Cell Medica granted Orphan Drug designation for novel cellular therapy

    Cell Medica announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to the company’s cancer immunotherapy treatment, referred to as CMD-003, under development for Epstein-Barr Virus (EBV) positive non-Hodgkin lymphomas. Additionally, the company announ ... more

    BASF increases prices for Vitamin E and A feed grade

    BASF increases prices for Vitamin E and A products for animal nutrition globally and with immediate effect. Prices will increase by 15% for all Vitamin E products and by 10% for all Vitamin A products. Existing contractual obligations with customers will be honored. more

  • Research

    Chewing gum rapid test for inflammation

    Chewing gum to screen for oral inflammation

    Dental implants occasionally entail complications: Six to fifteen percent of patients develop an inflammatory response in the years after receiving a dental implant. This is caused by bacteria destroying the soft tissue and the bone around the implant in the worst case. In future, patients ... more

    How protein islands form

    Researchers identify protein that inhibits the development of autoimmune diseases

    The immune system protects humans from threats such as, for example, disease-causing bacteria, and cancer as well. Yet if the system malfunctions, it can attack the body it is supposed to defend and cause autoimmune diseases such as type one diabetes mellitus or multiple sclerosis. The work ... more

    Gold shines through properties of nano biosensors

    Fluorescence in ligand-protected gold nanoclusters is an intrinsic property of the gold particles themselves

    With their remarkable electrical and optical properties, along with biocompatibility, photostability and chemical stability, gold nanoclusters are gaining a foothold in a number of research areas, particularly in biosensing and biolabeling. These gold nanoclusters are chemically protected b ... more

  • People

    Medigene announces formation of new Scientific Advisory Board

    Medigene AG announced the appointment of eight leading experts to its new immuno-oncology-focused Scientific Advisory Board (SAB). The SAB will consult the company with regard to strategic options and future perspectives within its research and development activities. The SAB will thereby f ... more

    Executive Board Changes at Merck

    The Personnel Committee of E. Merck KG has decided on changes in the responsibilities of the Executive Board of Merck KGaA, Darmstadt, effective September 1, 2017. Walter Galinat (61) will hand over responsibility for the Performance Materials business of Merck to his Executive Board collea ... more

    ZEISS Opts for Continuity: CEO Kaschke confirmed until 2020

    Executive Board Members Monz and Metz will also continue

    The Supervisory Board of Carl Zeiss AG has decided to continue the appointment of Dr. Michael Kaschke as President & CEO until 30 June 2020. Kaschke joined the ZEISS Group 25 years ago and has served on the Executive Board since 2000. He has been President & CEO of Carl Zeiss AG since 2011. ... more

  • Finances

    Eppendorf grows faster than the market

    During the first half of 2017, the Eppendorf Group achieved group sales of €327.9 million (prior-year period: €305.5 million). At 7.3% (6.6% when adjusted for currency effects), growth in sales lay above average market growth in the life science industry. Income from operations (EBIT) climb ... more

    Lonza Acquires Micro-Macinazione

    Swiss company expert in the field of microniziation

    Lonza has acquired Micro-Macinazione, providing micronization of active ingredients for the pharmaceutical and fine chemical industries. Micro-Macinazione, which had sales of ~ CHF 20 million in 2016, has 120 employees and is based in Monteggio, Switzerland. Micro-Macinazione was purchased ... more

    Merck Sets Course for Future Growth

    Life Science and Healthcare drive organic growth

    Merck reported an increase in sales in the second quarter of 2017 along with a decline in EBITDA pre exceptionals compared with the year-earlier period. Merck confirmed its earnings guidance following the first six months of 2017. “We have set the course for future growth. By focusing on in ... more

  • Cooperation

    Merck and Baylor College of Medicine Advance Vaccine Development and Manufacturing for Neglected Diseases

    Merck announced that it has formed a strategic alliance with Baylor College of Medicine (Texas, U.S.) and its vaccine product development partnership (PDP), Texas Children’s Hospital Center for Vaccine Development (Texas Children’s CVD), to advance vaccine research and development for negle ... more

    Successful conclusion of joint BRAIN AG and BASF SE research project

    Objective of the collaboration was the identification and development of new active ingredients for cosmetics

    Following several years of exclusive cooperation between BRAIN AG and BASF SE on the basis of a joint research project, BRAIN announced the successful conclusion of the project. The objective of the two companies’ collaborative research efforts was the identification and development of sens ... more

    A patent-free playground

    Researchers and industrial companies collaborate to create a new Open Science platform

    Along with a number of leading Danish industrial companies, Aarhus University has opted out of the patent rat race in a new collaboration on industrially relevant basic research. Researchers and companies from all over Denmark publish all their results and data on the innovative Open Scienc ... more

  • Technology

    New biomarker found for group of rare metabolic diseases

    A newly discovered biomarker associated with a rare metabolic disorder may facilitate better diagnosis and identification of new drugs for clinical trials for the disease, according to researchers in the Perelman School of Medicine at the University of Pennsylvania. Development of treatment ... more

    "Origami organs" can potentially regenerate tissues

    Bioactive tissue paper made from organs is pliable enough to fold into origami structures

    Northwestern Medicine scientists and engineers have invented a range of bioactive "tissue papers" made of materials derived from organs that are thin and flexible enough to even fold into an origami bird. The new biomaterials can potentially be used to support natural hormone production in ... more

    New, more sensitive sensor for evaluating drug safety

    A new technique for evaluating drug safety can detect stress on cells at earlier stages than conventional methods, which mostly rely on detecting cell death. The new method uses a fluorescent sensor that is turned on in a cell when misfolded proteins begin to aggregate -- an early sign of c ... more

  • Laws

    EPA to Grant Merck’s Patent Application for CRISPR Technology

    Related patent application recently awarded in Australia

    Merck announced the European Patent Office (EPO) has issued a “Notice of Intention to Grant” for Merck’s patent application covering the company’s CRISPR technology used in a genomic integration method for eukaryotic cells. The patent will provide Merck’s CRISPR genomic integration technolo ... more

    EMA prepares for Brexit

    Business continuity plan aims to preserve Agency’s ability to protect public and animal health

    The European Medicines Agency (EMA) has developed and initiated a business continuity plan to deal with the uncertainty and workload implications linked to the United Kingdom’s (UK’s) withdrawal from the European Union (EU) and the Agency’s relocation. “Preparing for the move, managing the ... more

    New ISPE Good Practice Guide

    Decommissioning of Pharmaceutical Equipment and Facilities

    The International Society for Pharmaceutical Engineering (ISPE) announced the release of their latest guidance document, ISPE Good Practice Guide: Decommissioning of Pharmaceutical Equipment and Facilities. This guide provides an overview of best practices to be used for the decommissioning ... more

  • Market

    EMA prepares for Brexit

    Business continuity plan aims to preserve Agency’s ability to protect public and animal health

    The European Medicines Agency (EMA) has developed and initiated a business continuity plan to deal with the uncertainty and workload implications linked to the United Kingdom’s (UK’s) withdrawal from the European Union (EU) and the Agency’s relocation. “Preparing for the move, managing the ... more

    Advanced Enzymes acquires evoxx

    The industrial biotechnology company evoxx technologies GmbH has become a part of specialty biotech company Advanced Enzyme Technologies Limited. Both companies announced that they have entered into a binding agreement about the acquisition of 100% stake in evoxx technologies. evoxx technol ... more

    Eurofins expands in India

    Acquires biopharmaceutical company Advinus from Tata Group

    Eurofins Scientific announces that it has signed an exclusive agreement with Tata Group to acquire Advinus Therapeutics, a preclinical and clinical phase contract research company for Safety Assessment, DMPK, CMC services, and Analytical R&D Services. The transaction is expected to close in ... more

  • Politics

    EPA to Grant Merck’s Patent Application for CRISPR Technology

    Related patent application recently awarded in Australia

    Merck announced the European Patent Office (EPO) has issued a “Notice of Intention to Grant” for Merck’s patent application covering the company’s CRISPR technology used in a genomic integration method for eukaryotic cells. The patent will provide Merck’s CRISPR genomic integration technolo ... more

    EMA prepares for Brexit

    Business continuity plan aims to preserve Agency’s ability to protect public and animal health

    The European Medicines Agency (EMA) has developed and initiated a business continuity plan to deal with the uncertainty and workload implications linked to the United Kingdom’s (UK’s) withdrawal from the European Union (EU) and the Agency’s relocation. “Preparing for the move, managing the ... more

    Highlights of June 2017 EMA Management Board meeting

    Focus on Brexit preparations and the development of the EU clinical trial portal and database

    Brexit preparations The Management Board of the European Medicines Agency (EMA) was updated on the Agency’s preparation for the withdrawal of the United Kingdom (UK) from the European Union (EU). Further to the UK’s invocation of Article 50 on 29 March 2017, EMA needs to prepare and is work ... more

  • Manufacturing

    Merck and Pfizer Collaborate with Corning to Modernize Pharmaceutical Glass Packaging

    Merck & Co., Pfizer and Corning Incorporated announced collaborations that have enabled the modernization of pharmaceutical packaging with the introduction of Corning Valor™ Glass. This revolutionary pharmaceutical glass packaging solution enhances the storage and delivery of today’s drug f ... more

    Recipharm and LIDDS establish industrial manufacturing capabilities

    Manufacturing line for prostate cancer product set up

    Recipharm and LIDDS have together set up a manufacturing line for LIDDS’ novel prostate cancer drug, Liproca®Depot, at Recipharm in Solna, Sweden. The manufacturing line is dedicated to the first product based on LIDDS’ innovative NanoZolid®technology. Clinical trial material has already be ... more

    Merck Refines Western European Life Science Production Site Network

    Merck announced the next phase in its continued efforts to drive operational excellence and improve efficiency of its Life Science business. The current site network in Western Europe will be refined, while the company invests € 90 million in four sites in Germany, Switzerland and France. S ... more

  • Career

    To be or not to be an academic: the question for all postdocs

    Becoming a full time academic at a research university is not an easy road.

    Becoming a full time academic at a research university is a dream for many young scientists, but it's not an easy road. For the past eight years, Dr Liz Elvidge has been helping postdoctoral researchers achieve this goal − but also advising them about a variety of different career paths and ... more

    Being fit Protects Against Health Risks Caused by Stress at Work

    It is a well-known fact that fitness and well-being go hand in hand. But being in good shape also protects against the health problems that arise when we feel particularly stressed at work. As reported by sports scientists from the University of Basel and colleagues from Sweden, it therefor ... more

    Freie Universität first institution in Germany to integrate medication management into the pharmacy study program

    The Institute of Pharmacy at Freie Universität Berlin is the first of its kind in Germany to integrate the field of medication management into the education of its pharmacy students. The goal is to put theoretical knowledge into practice even before the students have completed their study p ... more

News according to country
News archive
Newsletters

bionity.com Newsletter

The bionity.com newsletter keeps you informed about the current events in the fields of biotechnology, life sciences and medicine with news, products, company profiles and technical information.
Current edition

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE